The DxI 9000 Access immunoassay analyzer is revolutionizing laboratories by setting a new standard for efficiency. In time-sensitive environments such as clinics, hospitals, and urgent care settings, every minute is crucial. That is why Beckman Coulter has developed an instrument that allows laboratory staff to prioritize critical work while addressing the most pressing needs.
The DxI 9000 Access immunoassay analyzer has received its approval from United States Food and Drug Administration (FDA) and CE mark under the In Vitro Diagnostic Regulation (IVDR). It utilizes chemiluminescent immunoassay technology for the detection of analytes in patient samples such as sepsis marker (Procalcitonin PCT), cardiac markers (hsTnI), and hormones (TSH, Free T3, Free T4, FSH, LH and Prolactin).
Envision the possibilities and unlock the lab’s full potential.
ZeroDaily maintenance. The DxI 9000 analyzer eliminates daily maintenance, amplifying productivity with less than 15 minutes of automated cleaning per week.
Precision vision technology. This novel, patented machine vision technology utilizes multiple cameras with defined algorithms to detect and notify processing errors in real time, triggering course correction right away.
Simple solve onboard guide. This guide notifies problems and helps fix them before they derail progress. Additionally, when issues arise, step-by-step instructions empower the technician to resolve them quickly, minimizing downtime without requiring a service call.
Intuitive interface. The analyzer’s intuitive interface provides clear instructions to users of all skill levels. The user-friendly display visually represents system performance, guides users through operations, and facilitates quick onboarding and issue resolution.
Next-level output. The DxI 9000 analyzer’s industry-leading throughput (up to 450 tests per hour), optimized reagent consumption, and improved yields and traceability accelerate answers and amplify productivity.
Faster results. The Lumi-Phos PRO substrate reaches full glow in under a minute significantly reducing the time to obtain the first result. Additionally, preparation time is reduced as operators can directly load the reagents onto the analyzer without the need for thawing or equilibration.
Liberate from the laborious
Onboard aliquot management. Onboard, refrigerated aliquot storage frees the clinician from tracking down and reloading sample tubes for reflex or repeat tests.
Liquid, ready-to-use reagents. Simply remove the universal reagents from the refrigerator and load directly onto the analyzer — no need to thaw or remove caps/lids. Packets are automatically discarded once completed, saving time.
Tap into a menu that matters. Ready-to-use reagents shared across the Beckman Coulter immunoassay platform, more tests per pack for high-volume assays, and ready-to-use liquid reagent packs that can go directly from the refrigerator to the analyzer allows to refine clinical insights with a broad menu designed to streamline the high-volume and critical testing.
Intelligent automation. The DxI 9000 analyzer intelligently directs each tube down the appropriate path based on its urgency. With onboard sample aliquot storage for all necessary testing, tubes only stop once for a single aspiration. Clinical Informatics enables auto- verification and reflex rules, allowing tests to be automatically run from aliquot storage. This eliminates manual intervention and handling.
DxS IntelliServe. This secure and cloud-based remote service and diagnostics solution provides real-time monitoring and predictive analytics. It ensures maximum instrument availability and uninterrupted delivery of patient results.
With the DxI 9000, Beckman Coulter has developed a platform that addresses the needs of today’s labs – for speed, accuracy, and reliability. This low maintenance state-of-the-art immunoassay analyzer creates time for lab staff to focus on what matters the most – better clinical outcomes for the patient.